Lepu Biopharma Co., Ltd.
2157.HKHKSEHealthcareBiotechnology
Latest quote
HK$3.815
−HK$0.135 · -3.42%
2157.HK company overview
Regular session · HKT · Market data may be delayed.
Company profile
Company websiteLepu Biopharma Co., Ltd. operates as a biopharmaceutical enterprise, concentrating its efforts on the development of innovative oncology therapies. It maintains a broad pipeline of cancer-fighting products primarily aimed at the Chinese market. The company's therapeutic candidates encompass a range of modalities, including cutting-edge antibody-drug conjugates (ADCs), oncolytic virus treatments, and diverse immunotherapies. Among its immuno-oncology offerings are HX008 (an anti-PD-1 mAb) and LP002 (an anti-PD-L1 mAb). The ADC portfolio features MRG003 (targeting EGFR), MRG002 (targeting HER2), MRG001 (targeting CD20), MRG004A (targeting TF), and CMG901 (targeting CLDN18.2). Additionally, Lepu Biopharma is advancing the oncolytic virus CG0070, along with various combination therapies such as HX008+OH2, LP002+OH2, and HX008+LP002. Founded in 2018, the company is headquartered in Shanghai, China.
- Industry
- Biotechnology
- Sector
- Healthcare
- Headquarters
- CN
- CEO
- Sui Ziye
- Listed since
- Feb 23, 2022
- Employees
- 710
Market position
Day range
Current HK$3.815
52-week range
Current HK$3.815
- Open
- HK$3.985
- Previous close
- HK$3.95
- Volume
- 6.78M
- 0.68× average
- Average volume
- 9.93M
- Average daily volume
- Market cap
- 6.88B HKD
- Beta
- -0.42
- Market reference 1
- 50-day average
- HK$4.2693
- -10.64% below average
- 200-day average
- HK$4.9334
- -22.67% below average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 8.04B CNY
- P/E (TTM)
- 24.22×
- P/B (TTM)
- 4.18×
- P/S (TTM)
- 6.04×
- EV / EBITDA
- 44.98×
- Earnings yield
- 3.25%
- Free cash flow yield
- -1.06%
- Dividend yield
- 0.00%
Profitability & efficiency
- Gross margin
- 79.09%
- Operating margin
- 6.93%
- Net margin
- 24.89%
- Return on equity
- 18.36%
- Return on assets
- 8.21%
- Return on invested capital
- 3.18%
Financial health
- Debt / equity
- 0.84×
- Current ratio
- 0.98×
- Altman Z-score
- 1.48
- Piotroski F-score
- 4 of 9
2157.HK peers
ETFs holding 2157.HK
Funds reporting this stock among their holdings, ordered by reported position size.
iShares Core MSCI Emerging Markets ETFIEMG6.81M0.00%160B USD0.09%$81.57+0.64%
State Street SPDR Portfolio Emerging Markets ETFSPEM1.08M0.01%17.57B USD0.07%$52.38+0.61%
WisdomTree China ex-State-Owned Enterprises FundCXSE432.05K0.08%498.55M USD0.32%$38.6037+0.56%
iShares Core MSCI Total International Stock ETFIXUS260.26K0.00%60.91B USD0.07%$97.945+0.76%
Avantis Emerging Markets Equity ETFAVEM223.38K—27.89B USD0.33%$94.24+0.75%
iShares MSCI China Small-Cap ETFECNS218.69K0.33%66.48M USD0.59%$29.37+0.89%
Global X - Aging Population ETFAGNG184.39K0.19%96.18M USD0.50%$38.97+0.57%
iShares MSCI Emerging Markets Small-Cap ETFEEMS127.43K0.03%375.88M USD0.72%$74.72-0.20%iShares Core MSCI Emerging Markets ETFIEMG- Market value
- 6.81M
- Weight
- 0.00%
- AUM
- 160B USD
- Expense ratio
- 0.09%
- Price / 1D
- $81.57+0.64%
State Street SPDR Portfolio Emerging Markets ETFSPEM- Market value
- 1.08M
- Weight
- 0.01%
- AUM
- 17.57B USD
- Expense ratio
- 0.07%
- Price / 1D
- $52.38+0.61%
WisdomTree China ex-State-Owned Enterprises FundCXSE- Market value
- 432.05K
- Weight
- 0.08%
- AUM
- 498.55M USD
- Expense ratio
- 0.32%
- Price / 1D
- $38.6037+0.56%
iShares Core MSCI Total International Stock ETFIXUS- Market value
- 260.26K
- Weight
- 0.00%
- AUM
- 60.91B USD
- Expense ratio
- 0.07%
- Price / 1D
- $97.945+0.76%
Avantis Emerging Markets Equity ETFAVEM- Market value
- 223.38K
- Weight
- —
- AUM
- 27.89B USD
- Expense ratio
- 0.33%
- Price / 1D
- $94.24+0.75%
iShares MSCI China Small-Cap ETFECNS- Market value
- 218.69K
- Weight
- 0.33%
- AUM
- 66.48M USD
- Expense ratio
- 0.59%
- Price / 1D
- $29.37+0.89%
Global X - Aging Population ETFAGNG- Market value
- 184.39K
- Weight
- 0.19%
- AUM
- 96.18M USD
- Expense ratio
- 0.50%
- Price / 1D
- $38.97+0.57%
iShares MSCI Emerging Markets Small-Cap ETFEEMS- Market value
- 127.43K
- Weight
- 0.03%
- AUM
- 375.88M USD
- Expense ratio
- 0.72%
- Price / 1D
- $74.72-0.20%
Continue in GoAI
Research 2157.HKresearch.disclaimer